Target intelligence / Profile preview

Outer membrane protein OmpK36 (OmpK36)

Target
OmpK36
Molecular classification
Transporter, Other
01

Overview

Outer membrane protein OmpK36 is a major non-selective porin in the Gram-negative bacterium Klebsiella pneumoniae, homologous to Escherichia coli OmpC. It forms a trimeric beta-barrel channel that facilitates the passive diffusion of hydrophilic nutrients and small molecules, including beta-lactam antibiotics such as carbapenems and cephalosporins, across the outer membrane. OmpK36 is a critical determinant of antibiotic susceptibility; mutations that constrict the pore (such as Gly-Asp insertions in the L3 loop) or downregulate its expression significantly reduce drug entry, driving high-level resistance in carbapenemase-producing strains. Beyond its role in drug resistance, OmpK36 serves as a primary or secondary receptor for bacteriophages, making it a key target in phage therapy. It is also highly immunogenic and has been investigated as a candidate antigen for DNA and multi-epitope vaccines to prevent Klebsiella infections.

Other names
Outer membrane protein CPorin OmpK36Phosphoporin PhoEOmpCOmpK36 porin
02

Mechanism of action

Serves as a passive diffusion channel for beta-lactam antibiotic entry, a target antigen for vaccine-induced antibodies, and a receptor for bacteriophage binding.

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Rapid emergence of resistance mutationsLoss of porin expression leading to multidrug resistanceReduced bacterial fitness associated with certain porin mutations
06

Interacting drugs

10 more in the full profile.

07

Biomarkers

OmpK36 L3 loop mutationsOmpK36 expression levelompK36 promoter mutationsompK36 c25t synonymous mutation

Beyond the preview

Go deeper on Outer membrane protein OmpK36 (OmpK36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein OmpK36 (OmpK36).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call